Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting metabolic reprogramming in metastatic melanoma: The key role of nicotinamide phosphoribosyltransferase (NAMPT)

Published:2020-02 Issue: Volume:98 Page:192-201
ISSN:1084-9521
Container-title:Seminars in Cell & Developmental Biology
language:en
Short-container-title:Seminars in Cell & Developmental Biology

Author:

Audrito Valentina,Managò Antonella,Gaudino Federica,Deaglio Silvia

Funder

Italian Institute for Genomic Medicine Institutional

Gilead Fellowship program 2018

Ministry of Education University and Research-MIUR, PRIN

Progetto strategico di Eccellenza Dipartimentale

ITN INTEGRATA

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology

Reference146 articles.

1. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N. Engl. J. Med.,2011

2. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

3. Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma;Long;N. Engl. J. Med.,2014

4. Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial;Dummer;Lancet Oncol.,2018

5. Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma;Hu-Lieskovan;Sci. Transl. Med.,2015

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) in cancer: a patent review;Expert Opinion on Therapeutic Patents;2024-06-13

2. Identification of a metabolism-linked genomic signature for prognosis and immunotherapeutic efficiency in metastatic skin cutaneous melanoma;Medicine;2024-06-07

3. RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition;Molecular Cancer;2024-05-16

4. NAMPT mediates PDGF-induced pulmonary arterial smooth muscle cell proliferation by TLR4/NF-κB/PLK4 signaling pathway;European Journal of Pharmacology;2023-12

5. Recent advances of targeting nicotinamide phosphoribosyltransferase (NAMPT) for cancer drug discovery;European Journal of Medicinal Chemistry;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3